CORC

浏览/检索结果: 共6条,第1-6条 帮助

限定条件    
已选(0)清除 条数/页:   排序方式:
Combined everolimus and endocrine therapy in advanced HR-positive, HER2-negative Chinese breast cancer patients: a retrospective study 期刊论文
ANNALS OF TRANSLATIONAL MEDICINE, 2021, 卷号: 9
作者:  Shen, Xia-Bo;  Li, Guang-Liang;  Zheng, Ya-Bing;  Chen, Zhan-Hong;  Cao, Wen-Ming
收藏  |  浏览/下载:24/0  |  提交时间:2021/11/01
Everolimus combined with endocrine therapy in advanced HR-positive, HER2-negative Chinese breast cancer patients: A retrospective study. 期刊论文
JOURNAL OF CLINICAL ONCOLOGY, 2021, 卷号: 39
作者:  Shen, Xia-Bo;  Li, Guang-Liang;  Zheng, Ya-Bing;  Chen, Zhan-Hong;  Cao, Wen-Ming
收藏  |  浏览/下载:12/0  |  提交时间:2022/01/10
Ki67 and progesterone receptor status predicts sensitivity to palbociclib: a real-world study 期刊论文
ANNALS OF TRANSLATIONAL MEDICINE, 2021, 卷号: 9
作者:  Shao, Xiying;  Zheng, Yabing;  Cao, Wenming;  Shen, Xiabo;  Li, Guangliang
收藏  |  浏览/下载:52/0  |  提交时间:2021/06/15
Case Report: Significant Response to Immune Checkpoint Inhibitor Camrelizumab in a Heavily Pretreated Advanced ER+/HER2-Breast Cancer Patient With High Tumor Mutational Burden 期刊论文
FRONTIERS IN ONCOLOGY, 2021, 卷号: 10
作者:  Wang, Rong;  Yang, Yuchen;  Ye, Wei-Wu;  Xiang, Jianxing;  Chen, Songan
收藏  |  浏览/下载:44/0  |  提交时间:2021/04/26
Primary analysis of OVERSTEP: A multicenter, randomized clinical trial of capecitabine or endocrine therapy as a maintenance therapy after the 1st-line chemotherapy in hormone receptor positive and HER2-negative advanced/metastatic breast cancer 期刊论文
CANCER RESEARCH, 2021, 卷号: 81
作者:  Huang, Jian;  Shao, Xiying;  Cai, Li;  Shi, Yanxia;  Chen, Zhanhong
收藏  |  浏览/下载:28/0  |  提交时间:2021/04/26
A narrative review of risk factors and interventions for cancer-related cognitive impairment 期刊论文
ANNALS OF TRANSLATIONAL MEDICINE, 2021, 卷号: 9
作者:  Bai, Lu;  Yu, Enyan
收藏  |  浏览/下载:28/0  |  提交时间:2021/04/26


©版权所有 ©2017 CSpace - Powered by CSpace